stockrowReplimune Group, Inc. (REPL) vs Recursion Pharmaceuticals, Inc. (RXRX)
- Replimune Group, Inc. REPL 21.88 −6.01%
- Recursion Pharmaceuticals, Inc. RXRX 3.57 +0.56%
Replimune Group, Inc. and Recursion Pharmaceuticals, Inc. are both Biotechnology companies. Replimune Group, Inc. and Recursion Pharmaceuticals, Inc. are of similar size ($2.2B and $2.2B). Replimune Group, Inc. has the higher net margin (0.00% vs −697.1%) and the lower return on invested capital (−928.3% vs −88.5%). Across the 14 metrics below, Replimune Group, Inc. leads on 7 and Recursion Pharmaceuticals, Inc. on 7.
Valuation
Profitability
| Metric | REPL | RXRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 29.21% | 68.81% |
| Operating margin | 0.00% | (725.44%) | 0.00% |
| Net margin | 0.00% | (697.13%) | 0.00% |
| Free cash flow margin | 0.00% | (460.89%) | 0.00% |
| Return on equity | (115.80%) | (48.72%) | (50.30%) |
| Return on assets | (71.01%) | (36.29%) | (45.47%) |
| Return on invested capital | (928.27%) | (88.54%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack